SOUTH SAN FRANCISCO, Calif., March 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. today announced that James M. Gower, the company’s chairman and chief executive officer, is scheduled to present a company overview at the Cowen and Company 30th Annual Health Care Conference in Boston, Massachusetts on Tuesday, March 9th at 3:45 p.m. EST.
About Rigel (www.rigel.com)
Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and metabolic diseases. Rigel’s pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel’s productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.
CONTACT: Ryan Maynard, +1-650-624-1284, invrel@rigel.com
Web site: http://www.rigel.com/
